Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and ...

Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after ...

Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.

Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.

Five months ago, J&J also revealed its plan to spend $2 billion over the next 10 years to operate a 160,000-square-foot ...

Gujarat is leading India's solar cell manufacturing with significant investments and capacity expansions, positioning itself ...

Wang tells PV Tech Premium that copper offers a ‘a compelling combination’ of traits to replace silver. Image: AIKO. This Premium article, which was one of the most read Premium articles in 2025, has ...